Management of Antibiotics-Associated Diarrhea
Authors:
Open Access
- 1 January 2009
- journal article
- abstracts
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 54 (1) , 5-12
Abstract
Park HS, et al. Korean J Gastroenterol. 2009 Jul;54(1):5-12. https://doi.org/10.4166/kjg.2009.54.1.5Keywords
This publication has 43 references indexed in Scilit:
- Toxin B is essential for virulence of Clostridium difficileNature, 2009
- Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficileAntimicrobial Agents and Chemotherapy, 2008
- A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well‐tolerated in healthy volunteers: a randomized phase I trialBritish Journal of Clinical Pharmacology, 2008
- A case-control study of community-associated Clostridium difficile infectionJournal of Antimicrobial Chemotherapy, 2008
- Yield of Stool Culture with Isolate Toxin Testing versus a Two-Step Algorithm Including Stool Toxin Testing for Detection of Toxigenic Clostridium difficileJournal of Clinical Microbiology, 2007
- Increase inClostridium difficile–related Mortality Rates, United States, 1999–2004Emerging Infectious Diseases, 2007
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Bacteriotherapy Using Fecal FloraJournal of Clinical Gastroenterology, 2004
- Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrheaDiagnostic Microbiology and Infectious Disease, 1994
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989